PARAINFLUENZAE VIRAL LARYNGOTRACHEOBRONCHITIS

PARAINFLUENZAE VIRAL LARYNGOTRACHEOBRONCHITIS was reported 3 times

PARAINFLUENZAE VIRAL LARYNGOTRACHEOBRONCHITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SLAMF7-directed Immunostimulatory Antibody [EPC] 2 0.0004
1 Proteasome Inhibitor [EPC] 2 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
4 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
5 beta-Adrenergic Blocker [EPC] 2 0.0000
6 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Platinum-based Drug [EPC] 1 0.0000
9 Thalidomide Analog [EPC] 1 0.0000
10 Corticosteroid [EPC] 2 0.0000